Crown Electrokinetics (CRKN) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
28 Nov, 2025Company overview and business model
Develops and sells DynamicTint™ optical switching film for smart windows, targeting commercial, residential, and automotive markets.
Technology enables rapid electronic control of window opacity, offering energy efficiency and sustainability benefits.
Business model includes direct sales and long-term leases of Smart Window Inserts, with expansion into fiber optics infrastructure services.
Partners with major real estate and telecommunications firms, and has established supply agreements with key commercial property owners.
Manufacturing is vertically integrated, with facilities in Oregon for film and insert production, aiming for scalability and cost efficiency.
Financial performance and metrics
As of March 31, 2024, reported negative working capital of $2.8 million, cash of $0.3 million, and an accumulated deficit of $121.6 million.
Net cash used in operating activities was $2.7 million for Q1 2024, with ongoing operating losses and negative cash flows.
No cash dividends have been declared or are anticipated in the foreseeable future.
Use of proceeds and capital allocation
May receive up to $36.3 million in gross proceeds from the sale of common stock to Keystone Capital Partners under a purchase agreement.
Proceeds will be used for working capital, strategic initiatives, and general corporate purposes, with management retaining broad discretion over allocation.
Latest events from Crown Electrokinetics
- Q2 revenue hit $4.6M, losses narrowed, but going concern risks and new growth lines remain.CRKN
Q2 20241 Feb 2026 - Q3 revenue hit $8M, but ongoing losses and capital needs pose going concern risks.CRKN
Q3 202413 Jan 2026 - Registering up to $500M in flexible securities to fund growth in smart infrastructure divisions.CRKN
Registration Filing16 Dec 2025 - Vote on reverse stock split and auditor ratification to support Nasdaq compliance.CRKN
Proxy Filing1 Dec 2025 - Vote on a reverse stock split and auditor ratification to support Nasdaq compliance.CRKN
Proxy Filing1 Dec 2025 - Up to 20 million shares offered for resale to raise $100M, with significant dilution risk.CRKN
Registration Filing28 Nov 2025 - Revenue surged to $19.7M in 2024, with profitability expected by 2025 and robust project pipelines.CRKN
Investor Presentation9 Jul 2025 - 2024 revenue soared to $19.7M, with profitability targeted for 2025 and strong cash reserves.CRKN
Q4 20249 Jul 2025 - Revenue surged 309% but losses deepened and delisting threatens future viability.CRKN
Q1 20256 Jun 2025